White label ELPA - ClinicalTrials.eu

Study of AGP100 Safety and Effectiveness in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Recruiting

2 1 1
Study of anifrolumab safety in adults with primary antiphospholipid syndrome (APS)

Recruiting

2 1 1
Investigated Drugs:
- Anifrolumab
Study of SPN-817 (Huperzine A) in Adults with Focal Onset Seizures: Testing Safety and Effectiveness of Treatment

Recruiting

2 1
Investigated Drugs:
- HUPERZINE A
Study of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer’s disease patients

Recruiting

3 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- Trospium Chloride
- Xanomeline Tartrate
Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer’s disease

Recruiting

3 1
Investigated Drugs:
- Trospium Chloride
- Xanomeline Tartrate
+3
Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer’s disease

Recruiting

3 1
Investigated Drugs:
- Trospium Chloride
- Xanomeline Tartrate
+4
Study of bevacizumab and trifluridine combination given bi-weekly to reduce severe neutropenia in patients with metastatic colorectal cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Colorectal adenocarcinoma
Investigated Drugs:
- Bevacizumab
- Trifluridine
Study of Apitegromab Treatment in Children Under 2 Years Old with Spinal Muscular Atrophy (SMA)

Recruiting

2 1 1
Investigated Drugs:
- Apitegromab
Study of daratumumab, teclistamab and talquetamab combination treatment for frail patients with newly diagnosed multiple myeloma

Recruiting

2 1 1 1
Investigated Drugs:
Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+8

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies